GlassScriptPhysician profile
Beki Jean Denman
NPI 1356319727
$265.99
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2021: $14.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $95.01 | 2019-2021 | |
| Amgen INC. | $32.76 | 2019 | |
| Duchesnay USA Incorporated | $27.63 | 2019 | |
| Avion Pharmaceuticals | $24.26 | 2019 | |
| Covidien LP | $20.52 | 2019 | |
| Hologic Sales and Service, LLC | $15.79 | 2019 | |
| Ethicon US, LLC | $13.62 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.27 | 2019 | |
| Lupin INC. | $12.04 | 2019 | |
| Exeltis, USA INC. | $11.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beki Denman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.